Myriad Genetics buy Piper Sandler
Start price
11.11.25
/
50%
€5.70
Target price
11.11.26
€7.36
Performance (%)
-12.07%
Price
26.06.26
€5.01
Summary
This prediction is currently active. The prediction for Myriad Genetics disappoints with a performance of -12.07%. This prediction currently runs until 11.11.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 28.876% | 28.876% |
| iShares Core DAX® | -1,36 % | -2,16 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % |
| iShares S&P 500 | -1,66 % | -0,70 % |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Piper Sandler from $9.00 to $8.50. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat